Opinion statement Radiation-induced optic neuropathy (RON) is an iatrogenic complication that causes severe, irreversible vision loss in one or both eyes within the months to years following radiation therapy. Posterior RON is a rare but devastating toxicity of radiation applied to the visual pathways to treat paranasal sinus and skull base tumors. Anterior RON is an unavoidable consequence of proton beam irradiation or ophthalmic plaque treatment of orbital, choroidal, or retinal tumors. Various treatments aimed at stabilizing and ideally reversing vision loss have been investigated but only in small cases series. Systemic corticosteroids and anticoagulants, which are moderately effective when used for cerebral radiation necrosis, have shown no signs of benefit for RON. Hyperbaric oxygen therapy may promote short-term, partial recovery of vision in select patients, especially at partial pressures of at least 2.4 atm and when administered early after symptom onset. Reversal of visual deficits through treatment with systemic bevacizumab has been reported, but until controlled studies are performed, the side effect profile of stroke and myocardial infarction should limit its use in a population with predisposing cardiovascular risk factors. Intravitreal bevacizumab has shown promising results in patients with anterior RON, but repeated, long-term injections are required for sustained effect. As no intervention has been clearly shown to halt or reverse vision loss, larger prospective studies are needed to validate observed benefits for any of the treatments that have been described.
cardiovascular risk 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cardiovascular_disease

toxicity                      0.9999997534385179^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Toxicity              

RON                           0.9993376153305032^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Octane_rating         

corticosteroids               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Corticosteroid        

anticoagulants                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Anticoagulant         

visual pathways               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_system         

Hyperbaric oxygen therapy     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hyperbaric_medicine   

vision loss                   0.9999996767026528^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Vision_loss           

anterior                      0.9999999909289272^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

radiation                     0.9999999999261036^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Radiation_therapy     

tumors                        0.9999999979327185^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tumor                 

partial pressures             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Partial_pressure      

necrosis                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Necrosis              

bevacizumab                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bevacizumab           

atm                           0.9581069067157209^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Atmosphere_(unit)     

iatrogenic                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Iatrogenesis          

ophthalmic                    0.9999999988590389^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

stroke                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Stroke                

paranasal sinus               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Paranasal_sinuses     

vision loss                   0.9999996767026528^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Vision_loss           

RON                           0.9993376153305032^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Octane_rating         

bevacizumab                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bevacizumab           

skull base                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Base_of_skull         

prospective studies           0.9999999997905888^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Prospective_cohort_study

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

radiation                     0.9999999999261036^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Radiation_therapy     

choroidal                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Choroid               

irradiation                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Radiation_therapy     

myocardial infarction         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Myocardial_infarction 

RON                           0.9993376153305032^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Octane_rating         

RON                           0.9993376153305032^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Octane_rating         

radiation therapy             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Radiation_therapy     

cerebral                      0.9750656973256122^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

RON                           0.9993376153305032^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Octane_rating         

symptom                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Symptom               

tumors                        0.9999999979327185^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tumor                 

proton beam                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Charged_particle_beam 

optic neuropathy              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optic_neuropathy      

vision loss                   0.9999996767026528^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Vision_loss           

